Clinical Trials Logo

Clinical Trial Summary

The Ohio State University Early Psychosis Intervention Center is implementing a specialized clinical program to serve individuals who meet clinical high risk criteria for a psychosis. The purpose of this study is to evaluate the long-term outcomes among individuals participating in this clinical service.


Clinical Trial Description

The Ohio State University Early Psychosis Intervention Center (OSU EPICENTER) is implementing a specialized clinical program to serve individuals ages 12-25 who meet clinical high risk criteria for a psychosis (CHR-P). The purpose of this project is to evaluate (i) correlates of baseline characteristics among clinic participants; (ii) outcomes among individuals participating in this clinical service; and (iii) predictors and mediators of longitudinal outcomes among individuals participating in this clinical service. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03970005
Study type Observational [Patient Registry]
Source Ohio State University
Contact
Status Enrolling by invitation
Phase
Start date April 19, 2019
Completion date September 2026

See also
  Status Clinical Trial Phase
Terminated NCT03149107 - "Multimodal Prevention of Psychosis - Investigating Efficacy of N-Acetylcysteine and Psychotherapy in CHR-Patients" Phase 3
Recruiting NCT05131035 - Targeting Processing Speed Deficits to Improve Social Functioning and Lower Psychosis Risk N/A
Completed NCT01269710 - Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study N/A
Enrolling by invitation NCT05567848 - Accelerated TMS in Psychosis Phase 1/Phase 2
Recruiting NCT03751865 - Early Detection and Intervention for Women At-risk of Psychosis N/A
Recruiting NCT05052853 - Early Intervention of Prodromal Schizophrenia Using an NMDA Enhancer Phase 2
Recruiting NCT05877716 - EPI-MINN: Targeting Cognition and Motivation - National N/A
Completed NCT01597141 - Psychosis: Early Detection, Intervention and Prevention N/A
Completed NCT00169988 - Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms N/A
Completed NCT03447548 - Neurofeedback Training for High Risk Psychosis N/A
Completed NCT06190483 - Investigating the Role of Diazepam on Brain Function and Chemistry in Psychosis Risk N/A
Completed NCT01619319 - Effects of Cognitive Remediation on Cognition in Young People at Clinical High Risk of Psychosis N/A
Recruiting NCT05167396 - REtinal and VIsual Cortical Response in Early PSYchosis N/A
Terminated NCT00169949 - Aripiprazole Treatment of the Prodrome N/A
Recruiting NCT04338152 - Family-Focused Therapy for Individuals at High Clinical Risk for Psychosis: A Confirmatory Efficacy Trial N/A
Recruiting NCT05142735 - Effects of NAC on Symptoms of CHR Patients N/A
Enrolling by invitation NCT05532683 - Feasibility Trial of a Lifestyle Intervention for CHR-P N/A